Featured Research

from universities, journals, and other organizations

Labor Pain Comes From The Cervix

Date:
April 15, 2008
Source:
Karolinska Institutet
Summary:
Childbirth is painful, yet scientists are still somewhat in the dark about what actually causes the pain. A new doctoral thesis now shows where this pain comes from and opens the way to the development of improved methods of pain relief.

Childbirth is painful, yet scientists are still somewhat in the dark about what actually causes the pain. A new doctoral thesis from the Swedish medical university Karolinska Institutet now shows where this pain comes from and opens the way to the development of improved methods of pain relief.

In her thesis, obstetrician Berith Karlsson Tingåker has examined the source of pain during childbirth and how uterine sensitivity to pain changes during pregnancy. Her results show that labour pains mainly derive from the cervix, where the number of pain-related nerve fibres and receptors is much greater than in the uterus at full-term pregnancy.

Her thesis also shows that uterine pain sensitivity differs markedly between pregnant and non-pregnant women. In the latter, the entire uterus is pain-sensitive, while in the former, the pain-sensitive nerve fibres disappear almost completely from the main body of the uterus, but remain in the cervix.

Spinal anaesthesia is currently the most effective way of providing pain relief. However, it is a resource-demanding method and has other drawbacks that limit its practicability.

“The results create new opportunities for developing simpler and more effective methods of pain relief, with the focus on the cervix,” says Berith Karlsson Tingåker. “Women in Sweden and around the world, many of whom have no access to pain relief, are literally crying out for them.”

Thesis: Changes in human uterine innervation in term pregnancy and labor. Occurrence and roles of neurotrophins and TRPV1, Berith Karlsson Tingåker, The Department of Woman and Child Health, Karolinska Institutet.


Story Source:

The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.


Cite This Page:

Karolinska Institutet. "Labor Pain Comes From The Cervix." ScienceDaily. ScienceDaily, 15 April 2008. <www.sciencedaily.com/releases/2008/04/080412172431.htm>.
Karolinska Institutet. (2008, April 15). Labor Pain Comes From The Cervix. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/04/080412172431.htm
Karolinska Institutet. "Labor Pain Comes From The Cervix." ScienceDaily. www.sciencedaily.com/releases/2008/04/080412172431.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins